Abstract
It is difficult to estimate risk and it is even more difficult to estimate benefit. One might consider therefore, that is not worth dividing one into the other to produce a risk-benefit ratio which would be impossible to quantify. However, we do live in a real world in which we have to make decisions of risk to benefit and I am going to discuss the world I live in, which is trying to develop new drugs. Specifically I shall talk about the clinical development of drugs, where risk-benefit decisions have to be made rather frequently and regularly.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 MTP Press Limited
About this chapter
Cite this chapter
Brimblecombe, R.W. (1987). Risk-benefit decisions in human administration. In: Walker, S.R., Asscher, A.W. (eds) Medicines and Risk/Benefit Decisions. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3221-0_11
Download citation
DOI: https://doi.org/10.1007/978-94-009-3221-0_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7946-4
Online ISBN: 978-94-009-3221-0
eBook Packages: Springer Book Archive